DelveInsight's "Diverticulitis Market Insights, Epidemiology, and Market Forecast 2032" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Diverticulitis market size and shares analysis in the seven major markets (7MM).
Geographies Covered
The report analyses the Diverticulitis Market trends and developments in the seven major markets (i.e. the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.
Diverticulitis: An Overview
Diverticulitis is a digestive condition that affects the large intestine (bowel). Diverticulosis is a condition that occurs when small pouches, or sacs, form and push outward through weak spots in the wall of the colon. Diverticulitis occurs when one has diverticulosis and one or a few of the pouches in the wall of the colon become inflamed. In diverticulitis, the inflamed pouches most often cause pain in the lower left side of the abdomen. The pain is usually severe and comes on suddenly, though it can also be mild and get worse over several days. The intensity of the pain can change over time.
- According to the NIDDK, about 70,000 people are hospitalized for diverticular bleeding each year. Experts used to think that 10 to 25 % of people with diverticulosis would develop diverticulitis. However, newer research suggests that the percentage who develop diverticulitis may be much lower—less than 5 percent.
- According to the study conducted by Lisa L. Strate et al. (2019), Diverticulitis is a prevalent gastrointestinal disorder that is associated with significant morbidity and health care costs. Approximately 20% of patients with incident diverticulitis have at least 1 recurrence. The lifetime risk of diverticulitis in a person with diverticulosis was reported to range from 10% to 25%. Modern estimates based on colonoscopy and computed tomography (CT) indicate that <5% of individuals with diverticulosis develop diverticulitis.
As per DelveInsight, the Diverticulitis market size shall grow during the forecast period owing to the launch of upcoming therapies and an increased patient pool. Of the emerging therapies, the most anticipated product to get launched includes Aemcolo, Endari, and others. The pipeline for Diverticulitis- though not very vast - provides an opportunity for other key players to hold a great share in the market
Diverticulitis Market Outlook
The Diverticulitis market analysis section of the report helps to understand the current and forecasted Diverticulitis Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Diverticulitis Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Some of the key companies in the Diverticulitis Market include:
- Emmaus Medical
- Cosmo Pharmaceuticals
And many others
Diverticulitis Therapies covered in the report include:
- Aemcolo
- Endari
And many more
Diverticulitis Epidemiology Forecast
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Diverticulitis Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Diverticulitis Epidemiology Segmentation
- Total Prevalent Cases of Diverticulitis
- Gender-specific Prevalent Cases of Diverticulitis
- Diagnosed and Treatable Cases of Diverticulitis
- Age-specific Prevalent Cases of Diverticulitis
For more details, visit: Diverticulitis Market Trends